CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Insiders Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 20:23:01 05/08/2026 +03			5-day change	1st Jan Change
258.26 ^USD	+10.31%		+9.59%	+28.99%

06:41pm	Charles River Laboratories International, Inc., Q2 2026 Earnings Call, Aug 05, 2026
03:52pm	Charles River Laboratories International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 27, 2026	CI

Insiders

07-02	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
05-12	Charles River Laboratories International, Inc. Announces Board Elections	CI
02-18	Charles River Laboratories International, Inc. Announces Executive Appointments	CI
02-18	Charles River forecasts upbeat 2026 profit on improved demand for drug development services	RE
02-18	Charles River Q4 Adjusted Earnings, Revenue Decline; New CFO Named	MT
01-13	Charles River Laboratories Reports Two Planned Acquisitions; Names Namandje Bumpus as Chief Scientific and Innovation Officer	MT
01-13	Charles River Laboratories Names Dr. Namandjé N. Bumpus as Senior Vice President, Chief Scientific and Innovation Officer	CI
01-08	Charles River Laboratories International, Inc. Announces Chief Executive Officer Changes	CI
01-08	Charles River Laboratories International, Inc. Announces Changes in Board	CI
01-08	Charles River Laboratories International, Chair, President, CEO James Foster to Retire	MT
01-08	Charles River Laboratories announces planned retirement of James C. Foster	RE
15/10/25	Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption	CI
16/09/25	Charles River Laboratories announces chief financial officer transition	RE
16/09/25	Charles River Laboratories International, Inc. Announces Resignation of Flavia H. Pease, Corporate Executive Vice President from Her Role, Effective September 29, 2025	CI
16/09/25	Charles River Laboratories International, Inc. Announces Chief Financial Officer Transition	CI
16/09/25	Charles River Laboratories Says CFO to Step Down	MT
07/05/25	Charles River to add new directors, review business in agreement with Elliott	RE
07/05/25	Charles River Laboratories International, Inc. Announces Board Changes	CI
13/11/24	Charles River Laboratories International Insider Sold Shares Worth $1,647,418, According to a Recent SEC Filing	MT
12/08/24	Charles River Laboratories International Insider Sold Shares Worth $354,861, According to a Recent SEC Filing	MT
05/03/24	Charles River Laboratories International Insider Sold Shares Worth $959,545, According to a Recent SEC Filing	MT
02/03/24	Charles River Laboratories International Insider Sold Shares Worth $1,268,500, According to a Recent SEC Filing	MT
25/01/24	Charles River Laboratories International, Inc. Appoints Reshema Kemps-Polanco to Board of Directors	CI
17/01/24	Charles River Laboratories International, Inc. Announces Executive Changes	CI
19/12/23	Charles River Laboratories International Insider Sold Shares Worth $1,243,350, According to a Recent SEC Filing	MT